Sponsor:
University of Alabama at Birmingham
Code:
NCT05067231
Conditions
Natriuretic Peptides
Cardiovascular Diseases
Hypertension
Diabetes
Obesity
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Brief summary:
Conditions
Natriuretic Peptides
Cardiovascular Diseases
Hypertension
Diabetes
Obesity
Study ID
NCT05067231
Start date
Jan 1, 2022
Status verified date
Feb, 2026
Completion date
Jan 1, 2030
Anticipated
Primary completion date
Jan 1, 2030
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Enrollment
500 participants
Anticipated
Primary outcome measure
Central contacts
Locations
University of Alabama at Birmingham
Recruiting
Birmingham, Alabama, United States, 35294
Contacts
Principal Investigator:
Pankaj Arora, MD
Sponsor
University of Alabama at Birmingham
Last update posted
Feb 13, 2026
Last verified
Feb, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Alabama at Birmingham on 2026-02-13.